Follow

ChromoGenics AB

Nasdaq First North GM Stockholm (Sweden)

ChromoGenics develops and produces dynamic glass with controllable optical properties in Sweden and internationally. The Company offers ConverLight, an electrochromic glass, which provides UV protection for use in single glass pane and insulating glass unit solutions.
Go to market

Sector:
INDUSTRIALS
>
Building Products & Equipment
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
CHRO
SE0014730719
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in ChromoGenics AB with ticker CHRO
Status
Active
Amount of instruments
16 976 019
Currency
SEK
First trading date
23 Mar 2017
Rights issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Set-off issue
Sign in to buy
Set-off issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHRO TO4
SE0017486822
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO4
Status
Active
Amount of instruments
18 145 892
Currency
SEK
Trading period
22 Apr 2022 - 22 Mar 2023
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period February 21, 2023 - March 7, 2023, however, not less than SEK 2.50 and not more than SEK 4.50 per share.
Update (20.04.2022): First trading day for warrants TO4 is April 22, 2022.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHRO TO
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO
Status
Inactive
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period of fourteen (14) trading days ending March 7, 2023, however, not less than SEK 0.2 and not more than SEK 1.0 per share. Subscription period with the support of warrants will take place between March 13, 2023 - March 27, 2023.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
CHRO
SE0009496268
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in ChromoGenics AB with ticker CHRO
Status
Archived
Amount of instruments
707 334 300
Currency
SEK
First trading date
23 Mar 2017
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Set-off issue
Sign in to buy
Set-off issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
CHRO
SE0014730719
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in ChromoGenics AB with ticker CHRO
Status
Active
Amount of instruments
16 976 019
Currency
SEK
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Remuneration issue
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHRO TO1
SE0009554470
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO1
Status
Archived
Amount of instruments
13 921 312
Currency
SEK
Trading period
23 Mar 2017 - 29 May 2018
Terms
Four (4) warrants entitles the holder to subscribe for one (1) new share in the Company.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHRO TO2
SE0010662395
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO2
Status
Archived
Amount of instruments
18 974 669
Currency
SEK
Trading period
13 Feb 2018 - 29 Jan 2020
Terms
One (1) warrant of series TO 2 entitles the holder to subscribe for one (1) new share in the Company during the period from January 10, 2020 until January 31, 2020 for 3.50 SEK per share.
Update (27.02.2019): Recalculated terms: One (1) warrant of series TO 2 entitles the holder to subscribe for 1.62 new shares in the Company during the period from January 10, 2020 until January 31, 2020 for 2.17 SEK per share.
Update (23.08.2019): Recalculated terms: One (1) warrant of series TO 2 entitles the holder to subscribe for 2.02 new shares in the Company during the period from January 10, 2020 until January 31, 2020 for 1.74 SEK per share.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHRO TO3
SE0015195367
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO3
Status
Archived
Amount of instruments
2 829 336
Currency
SEK
Trading period
14 Jan 2021 - 29 Mar 2022
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the price corresponding to eighty (80) percent of the volume-weighted average price paid for the Company's share on Nasdaq First North GM Sweden during the periods from August 26, 2021 until September 8, 2021 and from February 28, 2022 until March 11, 2022, however, a minimum of SEK 8.00 and a maximum of SEK 12.00 per share. The subscription of shares with the support of warrants shall take place during the periods from September 13, 2021 until September 27, 2021 and from March 16, 2022 until March 31, 2022.
Update (08.01.2021): New equity right for trading, ChromoGenics TO3.
Update (10.01.2021): Subscription price for warrants TO3 has been set - SEK 8.0.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHRO TO4
SE0017486822
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO4
Status
Active
Amount of instruments
18 145 892
Currency
SEK
Trading period
22 Apr 2022 - 22 Mar 2023
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period February 21, 2023 - March 7, 2023, however, not less than SEK 2.50 and not more than SEK 4.50 per share.
Update (20.04.2022): First trading day for warrants TO4 is April 22, 2022.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
CHRO TO
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in ChromoGenics AB with ticker CHRO TO
Status
Inactive
Amount of instruments
Currency
SEK
First trading date
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share for the price which corresponds to seventy (70) percent of the volume-weighted average trading price during the period of fourteen (14) trading days ending March 7, 2023, however, not less than SEK 0.2 and not more than SEK 1.0 per share. Subscription period with the support of warrants will take place between March 13, 2023 - March 27, 2023.
Exercise
Sign in to buy
People
Fredrik Fränding
CEO
Johan Hedin
Chairman of the board
Anders Brännström
Board member
Peter Gustafson
Board member
Mari Broman
Board member
Andreas Jaeger
Board member
Fredrik Andersson
Board member
Company Details
Sector
INDUSTRIALS

Address
Ullforsgatan 15
Zip code
752 28
City/district
Uppsala
Country
Sweden (SE)
Registration number
556630-1809
LEI code
549300ULKN252K60BG25
First trade date
23 Mar 2017
Registration date
05 Aug 2002
Short name
CHRO

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More